Skip to main content

Table 1 Patient’s characteristics at presentation and after 2 years of tamsulosin monotherapy

From: The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study

Parameter

Valid N

Findings median (range)

At presentation

Age

437

63 years (50–90)

IPSS

437

21 (14–30)

Prostate volume

437

48 g (23–140)

Qmax

437

9.7 ml/s (5–14.5)

Serum total PSA

437

1.6 ng/ml (3–3.99)

At 2-year follow-up

IPSS

414

13 (7–26)

Prostate volume

414

53 g (26–165)

Qmax

414

15.6 ml/s (7.5–22)

IPSS change

414

− 8 (− 20 to 5)

Change of prostate volume

414

6.1 g (− 28 to 54)

Qmax change

414

5.55 ml/s (− 4.5 to 16)